Please Wait
Applying Filters...
menu
    • menu
    ChemWerth-PSE
    News
    ChemWerth Appoints New GSM to Expand India Generic API Reach

    12 Jan 2026

    // PRESS RELEASE

    ChemWerth Names New CEO

    18 Jun 2024

    // PRESS RELEASE

    Supply Chain Security If Your API Supply Is Important

    05 Sep 2023

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Chemwerth

    Contact Supplier

    Website

    CPhI North America

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.pharmacompass.com/video-pharmareel/chemwerth-inc/a-full-service-api-company
    Menu

    ChemWerth Inc

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    Key Products KEY PRODUCTS

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    INTERVIEW #SpeakPharma

    read-more
    read-more
    “Our unmatched efficiency and track record of faster DMF filings give our customers a critical competitive advantage”

    mic“Our unmatched efficiency and track record of faster DMF filings give our customers a critical competitive advantage”

    This week, SpeakPharma interviews Pete Werth III, the new president of ChemWerth, a company that has been at the forefront of the generic pharmaceutical industry for over four decades. He shares his vision for ChemWerth, which includes his commitment to strengthening global manufacturing relationships, and enhancing supply chain resilience. Additionally, he highlights the key aspects of a successful drug master file (DMF). HIGHLIGHTS// Pete Werth III, the new president of ChemWerth/ vision for ChemWerth/ commitment to strengthening global manufacturing relationships/ key aspects of a successful drug master file Your father, Peter J. Werth, is recognized as one of the founders of the generic pharmaceutical industry, having built ChemWerth from the ground up over four decades ago. How do you view his legacy? As you take the helm, what key lessons or principles from his leadership do you intend to carry forward? My father, Peter J. Werth, is a true pioneer in the generic pharmaceutical industry. Over his 42‐year tenure, he not only built ChemWerth from a humble garage startup into a global leader in generic API development but also established standards that many in our industry now take for granted. Under his leadership, we filed our very first DMF in 1987 and have since achieved more than 500 DMF filings. With an average review cycle of just 0.79, we have been far outperforming the industry average of 2.5 cycles. His focus on quality, regulatory excellence, and a relentless commitment to customers’ success set the foundation for our reputation as a trusted supplier of over 500 APIs sourced from more than 30 cGMP-certified facilities worldwide. Equally inspiring is his dedication to nurture long-term, mutually beneficial relationships with manufacturing partners across the US, Europe, India, and China, as well as his passion for giving back to the community through philanthropic initiatives. As I take the helm, I intend to build on his guiding principles — sustaining our high standards of quality and compliance while pursuing innovation in regulatory strategy, diversifying our supply chain, and embracing new technologies and approaches to remain competitive in an evolving market. I will also strive to continue his legacy of mentorship, ensuring that our company culture remains rooted in integrity and diligence, with an unyielding focus on making safe, affordable medicines available worldwide. HIGHLIGHTS// trusted supplier of over 500 APIs/ 30 cGMP-certified facilities worldwide/ embracing new technologies and approaches to remain competitive What are your top priorities as the new president of ChemWerth? How do you plan to strengthen and expand relationships with manufacturers worldwide? My immediate priorities as the new president are twofold: to enhance the value we deliver to our customers and, to deepen our relationships with our manufacturing partners worldwide. We will further diversify our supply chain and broaden our product portfolio. Our expansion plans include upgrading equipment, and hiring additional highly skilled scientists, engineers, and GMP auditors. We will also leverage our proprietary product selection and regulatory submission processes. These processes help us get the regulatory filing right the first time, and allows us to be approved 44 percent faster than the industry average. This helps our customers gain a competitive edge in the market. In essence, by strengthening operational excellence and expanding our global network, we intend to continue the company’s long-standing commitment to customer success and process innovation. We plan to reinforce our long-standing relationships with our manufacturers — especially those in strategic markets like China and India — by helping our partners meet the highest standards of regulatory compliance and current good manufacturing practice (cGMP) quality. This balanced approach of strengthening existing partnerships while pioneering new ones is key to maintaining and growing our competitive edge. HIGHLIGHTS// diversify our supply chain and broaden our product portfolio/ commitment to customer success and process innovation/ filings approved 44 percent faster than the industry average When ChemWerth last spoke to PharmaCompass, there was a mention of investing millions of dollars in expanding manufacturing partnerships in China and India. Can you elaborate on the success of these partnerships, and how have they contributed to ChemWerth’s overall growth? Our strategic, multimillion-dollar investments in manufacturing partnerships are a cornerstone of our growth strategy. Over the past few years, these joint ventures have proven their worth by diversifying our supply base and mitigating the risk of global supply chain disruptions — a lesson that became all too clear during the Covid-19 pandemic. These investments are already paying dividends. They help us support manufacturers producing steroids, hormones, veterinary products, and large-volume APIs, while also accelerating the development of small-molecule inhibitors and new generic APIs. We have ensured that our partners are equipped with the latest equipment and trained personnel to meet cGMP standards. By partnering with facilities in these markets, we now have access to state-of-the-art production capabilities that enable us to produce a wider range of APIs at competitive costs. The success of these partnerships is evident in our ability to consistently file DMFs rapidly — often on the first cycle — and deliver affordable, high-quality medicines to patients worldwide. This supports our clients’ growth trajectory and has helped us expand into new markets. This strategy has reinforced our global footprint — supporting our presence in 38 countries with over 100 products — and positioned us well to capitalize on a global generic drug market projected to grow at a compounded annual growth rate of 5.4 percent from 2022 to 2030, to reach a size of US$ 671 billion by 2030. HIGHLIGHTS// strategic multimillion-dollar investments/ support manufacturers producing steroid, hormone, veterinary products/ development of small-molecule inhibitors and new generic APIs/ ensured partners are equipped with the latest equipment and trained personnel ChemWerth has an impressive track record, and an over 40-year relationship with the US Food and Drug Administration (FDA). What are the key aspects of a successful DMF? Are there specific challenges manufacturers face in preparing DMFs, and how does ChemWerth help them overcome these hurdles? ChemWerth’s record of filing over 500 DMFs in 38 countries reflects our commitment to excellence in regulatory compliance and quality management. A successful DMF is built on comprehensive documentation that rigorously follows cGMP guidelines, robust analytical validation, and detailed tracking of every step. Every DMF we file meticulously details the entire manufacturing process — from raw material acquisition to final batch production. This comprehensive approach ensures that our submissions meet the rigorous quality, safety, and efficacy standards expected by the FDA. Our team stays continuously updated on the evolving guidelines and protocols, which allows us to file DMFs that align with current FDA practices. We recognize that many manufacturers face challenges such as complex regulatory requirements, lengthy review cycles, and the need for precise coordination between various production stages. ChemWerth helps them overcome these hurdles by offering end-to-end regulatory support, detailed internal audits, and continuous training on cGMP and FDA requirements. Our efficiency is a critical competitive advantage. By receiving approvals 44 percent faster than the industry average, we help our customers get their products to market faster, resulting in larger market share and increased profits. HIGHLIGHTS// over 500 DMFs in 38 countries/ robust analytical validation/ end-to-end regulatory support What is your vision for ChemWerth over the next few years? How do you plan to navigate the challenges and opportunities in the generic pharmaceutical industry? I plan to continue to add value for our customers, and look for innovative ways to compete in today’s generic pharmaceutical landscape. At ChemWerth, our vision for the future is rooted in both our proud legacy and our relentless drive for innovation. We will further diversify our supply chain and expand our product portfolio. We have begun leveraging our expertise to supply APIs for biosimilars and new drug applications (NDAs), while maintaining our reputation for rapid regulatory approvals. With unwavering determination, we uphold our “First to Quality. Fast to Market.” approach — delivering high-quality APIs to customers worldwide while leveraging our expertise to give them a competitive edge in their markets. HIGHLIGHTS// supply APIs for biosimilars and NDAs/ give customers a competitive edge in their markets 

    Impressions: 1777

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage

    Radio Compass
    12 Mar 2025
    Share info Share

    VLOG #PharmaReel

    read-more

    ReelPharmaA Full-Service API CompanyA Full-Service API Company

    A Full-Service API Company
    A Full-Service API Company

    reelA Full-Service API Company

    This PharmaReel showcases ChemWerth, a full-service generic API company with over 40 years of experience, offering cGMP-quality APIs through 30+ manufacturing partners across the US, EU, India, and China, backed by 550+ global filings, and expertise in new product development, compliance, and logistics.

    Impressions: 2626

    read-more

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2026

    read-more

      https://www.pharmacompass.com/pdf/party/content/chemwerth-inc-party-content-99334.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/chemwerth-inc-party-content-27403.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Nitrosamine & Genotoxic Impurity 2025

    read-more

      https://www.pharmacompass.com/pdf/party/content/chemwerth-inc-party-content-76959.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    The ChemWerth Advantage 2025

    read-more

      https://www.pharmacompass.com/pdf/party/content/chemwerth-inc-party-content-50147.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    ChemWerth Celebrates 40 Years in Business

    read-more

      https://www.pharmacompass.com/pdf/party/content/chemwerth-inc-party-content-23090.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    A New Look at ANDA Approvals

    read-more

      https://www.pharmacompass.com/pdf/party/content/chemwerth-inc-party-content-1642651741.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    ChemWerth Appoints New GSM to Expand India Generic API Reach
    ChemWerth Appoints New GSM to Expand India Generic API Reach

    12 Jan 2026

    // PRESS RELEASE

    https://chemwerth.com/chemwerth-appoints-new-general-sales-manager-to-increase-its-generic-api-footprint-in-india/

    PRESS RELEASE
    12 Jan 2026
    Share Share
    ChemWerth Names New CEO
    ChemWerth Names New CEO

    18 Jun 2024

    // PRESS RELEASE

    https://chemwerth.com/announcement-of-leadership-changes/

    PRESS RELEASE
    18 Jun 2024
    Share Share
    Supply Chain Security If Your API Supply Is Important
    Supply Chain Security If Your API Supply Is Important

    05 Sep 2023

    // PRESS RELEASE

    https://chemwerth.com/supply-chain-security-if-your-api-supply-is-important-you-should-take-5-minutes-to-read-this/

    PRESS RELEASE
    05 Sep 2023
    Share Share
    PharmaTech Outlook Names ChemWerth as a Top Drug Discovery of 2023
    PharmaTech Outlook Names ChemWerth as a Top Drug Discovery of 2023

    24 May 2023

    // PRESS RELEASE

    https://chemwerth.com/pharmatech-outlook-names-chemwerth-as-a-top-drug-discovery-and-development-company-of-2023-2/

    PRESS RELEASE
    24 May 2023
    Share Share
    Peter Werth Recieves Honorary Degree From Housatonic College
    Peter Werth Recieves Honorary Degree From Housatonic College

    23 May 2023

    // PRESS RELEASE

    https://chemwerth.com/peter-werth-recieves-honorary-degree-from-housatonic-community-college/

    PRESS RELEASE
    23 May 2023
    Share Share
    Woodbridge Pharma Company ChemWerth Eyes Overseas Expansion
    Woodbridge Pharma Company ChemWerth Eyes Overseas Expansion

    21 May 2023

    // PRESS RELEASE

    https://chemwerth.com/woodbridge-pharma-company-chemwerth-eyes-overseas-expansion/

    PRESS RELEASE
    21 May 2023
    Share Share
    Contact Chemwerth Inc and get a quotation

    Chemwerth Inc is a supplier offers 114 products (APIs, Excipients or Intermediates).

    Find Foscarnet Sodium bulk with DMF, CEP offered by Chemwerth Inc

    Find Ropivacaine Hydrochloride bulk with DMF, CEP offered by Chemwerth Inc

    Find Argatroban Monohydrate bulk with DMF offered by Chemwerth Inc

    Find Arsenic Trioxide bulk with DMF offered by Chemwerth Inc

    Find Azacitidine bulk with DMF offered by Chemwerth Inc

    Find Bromfenac Sodium bulk with DMF offered by Chemwerth Inc

    Find Clevidipine bulk with DMF offered by Chemwerth Inc

    Find Dexmedetomidine Hydrochloride bulk with DMF offered by Chemwerth Inc

    Find Eltrombopag bulk with DMF offered by Chemwerth Inc

    Find Epinastine Hydrochloride bulk with DMF offered by Chemwerth Inc

    Find Esmolol Hydrochloride bulk with DMF offered by Chemwerth Inc

    Find Etomidate bulk with DMF offered by Chemwerth Inc

    Find Fosphenytoin Sodium bulk with DMF offered by Chemwerth Inc

    Find Lapatinib Ditosylate bulk with DMF offered by Chemwerth Inc

    Find Melphalan bulk with DMF offered by Chemwerth Inc

    Find Melphalan Hydrochloride bulk with DMF offered by Chemwerth Inc

    Find Methylene Blue bulk with DMF offered by Chemwerth Inc

    Find Milrinone bulk with DMF offered by Chemwerth Inc

    Find Mitomycin bulk with DMF offered by Chemwerth Inc

    Find Nelarabine bulk with DMF offered by Chemwerth Inc

    Find Nepafenac bulk with DMF offered by Chemwerth Inc

    Find Nicardipine Hydrochloride bulk with DMF offered by Chemwerth Inc

    Find Pemetrexed Disodium bulk with DMF offered by Chemwerth Inc

    Find Penciclovir bulk with DMF offered by Chemwerth Inc

    Find Selenious Acid bulk with DMF offered by Chemwerth Inc

    Find Sodium Nitroprusside bulk with DMF offered by Chemwerth Inc

    Find Tetrabenazine bulk with DMF offered by Chemwerth Inc

    Find Tiagabine Hydrochloride bulk with DMF offered by Chemwerth Inc

    Find Ziprasidone Mesylate bulk with DMF offered by Chemwerth Inc

    Find Tobramycin bulk offered by Chemwerth Inc

    Find Abaloparatide bulk offered by Chemwerth Inc

    Find Abemaciclib bulk offered by Chemwerth Inc

    Find Afoxolaner bulk offered by Chemwerth Inc

    Find Amifostine Trihydrate bulk offered by Chemwerth Inc

    Find Amphotericin B bulk offered by Chemwerth Inc

    Find Angiotensin II bulk offered by Chemwerth Inc

    Find Atosiban bulk offered by Chemwerth Inc

    Find Avatrombopag Maleate bulk offered by Chemwerth Inc

    Find Bivalirudin bulk offered by Chemwerth Inc

    Find Cabotegravir bulk offered by Chemwerth Inc

    Find Cabotegravir Sodium bulk offered by Chemwerth Inc

    Find Calcium Gluconate bulk offered by Chemwerth Inc

    Find Carmustine bulk offered by Chemwerth Inc

    Find Cefovecin bulk offered by Chemwerth Inc

    Find Cetrorelix Acetate bulk offered by Chemwerth Inc

    Find Clascoterone bulk offered by Chemwerth Inc

    Find Clindamycin Hydrochloride bulk offered by Chemwerth Inc

    Find Cyclosporine bulk offered by Chemwerth Inc

    Find Dalbavancin bulk offered by Chemwerth Inc

    Find Daptomycin bulk offered by Chemwerth Inc

    Find Disodium Pamidronate Pentahydrate bulk offered by Chemwerth Inc

    Find Edaravone bulk offered by Chemwerth Inc

    Find Enoxaparin Sodium bulk offered by Chemwerth Inc

    Find Eptifibatide bulk offered by Chemwerth Inc

    Find Etelcalcetide bulk offered by Chemwerth Inc

    Find Etoposide bulk offered by Chemwerth Inc

    Find Ferric Maltol bulk offered by Chemwerth Inc

    Find Fidaxomicin bulk offered by Chemwerth Inc

    Find Fludarabine Phosphate bulk offered by Chemwerth Inc

    Find Fluralaner bulk offered by Chemwerth Inc

    Find Fosaprepitant bulk offered by Chemwerth Inc

    Find Ganirelix bulk offered by Chemwerth Inc

    Find Grapiprant bulk offered by Chemwerth Inc

    Find Heparin Sodium bulk offered by Chemwerth Inc

    Find Icatibant Acetate bulk offered by Chemwerth Inc

    Find Ifosfamide bulk offered by Chemwerth Inc

    Find Imepitoin bulk offered by Chemwerth Inc

    Find Indocyanine Green bulk offered by Chemwerth Inc

    Find Isavuconazonium Sulfate bulk offered by Chemwerth Inc

    Find Isosulfan Blue bulk offered by Chemwerth Inc

    Find Lanreotide Acetate bulk offered by Chemwerth Inc

    Find Letermovir bulk offered by Chemwerth Inc

    Find Leuprolide Acetate bulk offered by Chemwerth Inc

    Find Linaclotide bulk offered by Chemwerth Inc

    Find Liraglutide bulk offered by Chemwerth Inc

    Find Lufenuron bulk offered by Chemwerth Inc

    Find Lurbinectedin bulk offered by Chemwerth Inc

    Find Maropitant bulk offered by Chemwerth Inc

    Find Medetomidine bulk offered by Chemwerth Inc

    Find Melengestrol Acetate bulk offered by Chemwerth Inc

    Find Midostaurin bulk offered by Chemwerth Inc

    Find Milbemycin Oxime bulk offered by Chemwerth Inc

    Find Nitenpyram bulk offered by Chemwerth Inc

    Find Octreotide Acetate bulk offered by Chemwerth Inc

    Find Omadacycline bulk offered by Chemwerth Inc

    Find Orbifloxacin bulk offered by Chemwerth Inc

    Find Pancrelipase bulk offered by Chemwerth Inc

    Find Pasireotide bulk offered by Chemwerth Inc

    Find Perampanel bulk offered by Chemwerth Inc

    Find Pergolide Mesylate bulk offered by Chemwerth Inc

    Find Polymyxin B Sulfate bulk offered by Chemwerth Inc

    Find Ponazuril bulk offered by Chemwerth Inc

    Find Pradofloxacin bulk offered by Chemwerth Inc

    Find Sarolaner bulk offered by Chemwerth Inc

    Find Semaglutide bulk offered by Chemwerth Inc

    Find Setmelanotide Acetate bulk offered by Chemwerth Inc

    Find Sirolimus bulk offered by Chemwerth Inc

    Find Spinosyn D bulk offered by Chemwerth Inc

    Find Tacrolimus bulk offered by Chemwerth Inc

    Find Teduglutide bulk offered by Chemwerth Inc

    Find Teriparatide bulk offered by Chemwerth Inc

    Find Terlipressin Acetate bulk offered by Chemwerth Inc

    Find Tildipirosin bulk offered by Chemwerth Inc

    Find Tirzepatide bulk offered by Chemwerth Inc

    Find Toceranib Phosphate bulk offered by Chemwerth Inc

    Find Treosulfan bulk offered by Chemwerth Inc

    Find Treprostinil Diolamine bulk offered by Chemwerth Inc

    Find Treprostinil Sodium bulk offered by Chemwerth Inc

    Find Trilostane bulk offered by Chemwerth Inc

    Find Vancomycin Hydrochloride bulk offered by Chemwerth Inc

    Find Vecuronium Bromide bulk offered by Chemwerth Inc

    Find Viloxazine Hydrochloride bulk offered by Chemwerth Inc

    Find Vinorelbine Tartrate bulk offered by Chemwerth Inc

    Find Ziconotide Acetate bulk offered by Chemwerth Inc

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.